HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correlation between risk of hepatitis B virus recurrence and tissue expression of covalently closed circular DNA in living donor liver transplant recipients treated with high-dose hepatitis B immunoglobulin.

AbstractBACKGROUND AND AIMS:
Despite the application of prophylaxis, the risk of hepatitis B virus (HBV) recurrence remains. However, actual mechanism(s) and definite risk factor(s) are obscure. The present study examined the correlation between the HBV load in liver explants and post-liver transplant (OLT) HBV recurrence.
METHODS:
HBV DNA was extracted from liver tissue taken from 50 living donor OLT (LDLT) patients using the QuickGene DNA Tissue Kit S (Fujifilm, Tokyo, Japan) and subjected to real-time polymerase chain reaction with the following primers: 5'-CACATGGCCTCCAAGGAGTAA-3' (forward primer) and 5'-TGAGGGTCTCTCTCTTCCTCTTGT-3' (reverse primer). To prevent HBV infection, patients were treated daily with high-dose (10,000 IU) hepatitis B immunoglobulin (HBIG) for the first week after LDLT. They then received weekly doses for the next month and then monthly doses for ≤1 year. If the anti-hepatitis surface antigen antibody titer was <1,000 IU/L, an antiviral agent (AVA) was added to the regimen.
RESULTS:
The mean (±SD) tissue HBV DNA and covalently closed circular DNA (cccDNA) loads were -0.8 ± 1.2 (range, -2.9 to 2.6) and -2.3 ± 1.1 (range, -4.6 to 0.6) log10 copies/cell, respectively. There was a significant correlation between serum and tissue HBV DNA (r = 0.65; P = .00) and cccDNA concentrations (r = 0.55; P = .00). Six patients suffered HBV recurrence and 9 required additional AVA. There was no direct correlation between HBV recurrence and tissue cccDNA concentration. However, the concentration of cccDNA was significantly greater those patients suffering recurrence and receiving AVA treatment (high-risk group).
CONCLUSION:
High tissue cccDNA concentrations may be a risk factor for HBV recurrence despite high-dose HBIG prophylaxis.
AuthorsG-W Song, C-S Ahn, S-G Lee, S Hwang, K-H Kim, D-B Moon, T-Y Ha, D-H Jung, G-C Park, S-H Kang, B-H Jung, N Kim
JournalTransplantation proceedings (Transplant Proc) Vol. 46 Issue 10 Pg. 3548-53 (Dec 2014) ISSN: 1873-2623 [Electronic] United States
PMID25498087 (Publication Type: Journal Article)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • DNA, Circular
  • DNA, Viral
  • Immunoglobulins
  • hepatitis B hyperimmune globulin
Topics
  • Adult
  • Aged
  • DNA, Circular (genetics)
  • DNA, Viral (analysis)
  • Female
  • Hepatitis B (drug therapy, epidemiology, virology)
  • Hepatitis B virus (genetics)
  • Humans
  • Immunization, Passive
  • Immunoglobulins (administration & dosage)
  • Incidence
  • Japan (epidemiology)
  • Liver Transplantation
  • Living Donors
  • Male
  • Middle Aged
  • Real-Time Polymerase Chain Reaction
  • Recurrence
  • Republic of Korea (epidemiology)
  • Risk
  • Transplant Recipients

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: